AWHL - Aspira Women's Health Inc.
0.3499
0.030 8.545%
Share volume: 14,014
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.32
0.03
0.09%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-19-2025 | 08-12-2025 | 11-14-2025 | |
| Cash flow financing | 4.645 M | -33.000 K | 2.869 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | 1.543 M | 0.000 | 2.264 M | |
| Net income | -1.853 M | -2.666 M | -4.892 M | |
| Depreciation | 13.000 K | 11.000 K | 50.000 K | |
| Changes in inventories | -66.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | -393.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 8.000 K | |
| Cash Change | 1.543 M | -1.767 M | 2.117 M |